Exposure to air pollution as an environmental determinant of how Sjögren's disease is expressed at diagnosis.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
29 Nov 2023
Historique:
received: 02 11 2023
accepted: 03 11 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: aheadofprint

Résumé

To analyse how the potential exposure to air pollutants can influence the key components at the time of diagnosis of Sjögren's phenotype (epidemiological profile, sicca symptoms, and systemic disease). For the present study, the following variables were selected for harmonization and refinement: age, sex, country, fulfilment of 2002/2016 criteria items, dry eyes, dry mouth, and overall ESSDAI score. Air pollution indexes per country were defined according to the OECD (1990-2021), including emission data of nitrogen and sulphur oxides (NO/SO), particulate matter (PM2.5 and 1.0), carbon monoxide (CO) and volatile organic compounds (VOC) calculated per unit of GDP, Kg per 1000 USD. The results of the chi-square tests of independence for each air pollutant with the frequency of dry eyes at diagnosis showed that, except for one, all variables exhibited p-values <0.0001. The most pronounced disparities emerged in the dry eye prevalence among individuals inhabiting countries with the highest NO/SO exposure, a surge of 4.61 percentage points compared to other countries, followed by CO (3.59 points), non-methane (3.32 points), PM2.5 (3.30 points), and PM1.0 (1.60 points) exposures. Concerning dry mouth, individuals residing in countries with worse NO/SO exposures exhibited a heightened frequency of dry mouth by 2.05 percentage points (p<0.0001), followed by non-methane exposure (1.21 percentage points increase, p=0.007). Individuals inhabiting countries with the worst NO/SO, CO, and PM2.5 pollution levels had a higher mean global ESSDAI score than those in lower-risk nations (all p-values <0.0001). When systemic disease was stratified according to DAS into low, moderate, and high systemic activity levels, a heightened proportion of individuals manifesting moderate/severe systemic activity was observed in countries with worse exposures to NO/SO, CO, and PM2.5 pollutant levels. For the first time, we suggest that pollution levels could influence how SjD appears at diagnosis in a large international cohort of patients. The most notable relationships were found between symptoms (dryness and general body symptoms) and NO/SO, CO, and PM2.5 levels.

Identifiants

pubmed: 38019154
pii: 20520
doi: 10.55563/clinexprheumatol/p1r1j4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Xu Dong (X)
Zhao Yan (Z)
Xiaomei Li (X)
Li Wang (L)
Peter Olsson (P)
Thomas Mandl (T)
Raphaele Seror (R)
Xavier Mariette (X)
Arjan Vissink (A)
Hendrika Bootsma (H)
Debashish Danda (D)
Vasco C Romão (VC)
Matilde Bandeira (M)
Manuel Silvério-António (M)
Roser Solans (R)
Carlos Galisteo (C)
Demian Sene (D)
David Isenberg (D)
Paola Cipriani (P)
Valerie Devauchelle (V)
Tamer Gheita (T)
Marcos Vázquez (M)
Jacques Morel (J)
Sandra Consani (S)
S-K Kwok (SK)
S-H Park (SH)
Marika Kvarnstrom (M)
Marie Wahren-Herlenius (M)
P Ericka Díaz Cuiza (PE)
B E Herrera (BE)
Toshimasa Shimizu (T)
Andrés González-García (A)
Sheila Melchor-Díaz (S)
Michele Bombardieri (M)
Adrian Lees (A)
Suzanne Arends (S)
Elena Treppo (E)
Simone Longhino (S)
Valeria Manfrè (V)
Maria Teresa Rizzo (MT)
Agata Sebastian (A)
Piotr Wiland (P)
Roberto Gerli (R)
Sarah Downie-Doyle (S)
Alain Saraux (A)
Gunnel Nordmark (G)
César Morcillo (C)
Lluís González-de-Paz (L)
Antoni Sisó-Almirall (A)

Auteurs

Pilar Brito-Zerón (P)

Autoimmune Diseases Unit, Research and Innovation Group in Autoimmune Diseases, Sanitas Digital Hospital, Hospital-CIMA-Centre Mèdic Milenium Balmes Sanitas, Barcelona, Spain.

Alejandra Flores-Chávez (A)

Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain.

Wan-Fai Ng (WF)

Newcastle NIHR Biomedical Research Centre, The United Kingdom Primary Sjögren's Syndrome Registry, Newcastle upon Tyne, UK.

Ildiko Fanny Horváth (I)

Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Hungary.

Astrid Rasmussen (A)

Genes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Roberta Priori (R)

Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, and Saint Camillus International University of Health Science, UniCamillus, Rome, Italy.

Chiara Baldini (C)

Rheumatology Unit, University of Pisa, Italy.

Berkan Armagan (B)

Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Burcugül Özkiziltaş (B)

Department of Internal Medicine, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey.

Sonja Praprotnik (S)

Department of Rheumatology, University Medical Centre, Ljubljana, Slovenia.

Yasuori Suzuki (Y)

Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

Luca Quartuccio (L)

Division of Rheumatology, Department of Medicine, University of Udine, University Hospital Santa Maria della Misericordia, Udine, Italy.

Gabriela Hernandez-Molina (G)

Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico.

Kerem Abacar (K)

Marmara University, School of Medicine, Istanbul, Turkey.

Elena Bartoloni (E)

Rheumatology Unit, Department of Medicine, University of Perugia, Italy.

Maureen Rischmueller (M)

Department of Rheumatology, The Queen Elizabeth Hospital, Discipline of Medicine, University of Adelaide, South Australia, Australia.

Fabiola Reis-de Oliveira (F)

Clinica Hospital de Ribeirao Preto Medical School, University of São Paulo, Brazil.

Virginia Fernandes Moça Trevisani (V)

Division of Health Based Evidence, Federal University of São Paulo, Brazil.

Ciprian Jurcut (C)

Department of Internal Medicine, Carol Davila Central Military Emergency Hospital, Bucharest, Romania.

Cecilia Fugmann (C)

Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Francesco Carubbi (F)

Internal Medicine and Nephrology Unit, Department of Medicine, ASL Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy.

Benedikt Hofauer (B)

Otorhinolaryngology, Head and Neck Surgery, Medical University Innsbruck, Austria.

Valeria Valim (V)

Federal University of Espírito Santo, Brazil.

Sandra G Pasoto (SG)

Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina da Universidade de São Paulo, Brazil.

Soledad Retamozo (S)

Department of Rheumatology, Hospital Quirón Salud, Barcelona, Spain.

Fabiola Atzeni (F)

IRCCS Galeazzi Orthopedic Institute, Milan, and Rheumatology Unit, University of Messina, Italy.

Eva Fonseca-Aizpuru (E)

Department of Internal Medicine, Hospital de Cabueñes, Gijón, Spain.

Miguel López-Dupla (M)

Department of Internal Medicine, Hospital Joan XXIII, Tarragona, Spain.

Roberto Giacomelli (R)

Clinical Unit of Rheumatology and Clinical Immunology, University of Rome Campus Biomedico, Rome, Italy.

Hideki Nakamura (H)

Division of Haematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Oyaguchi Kami-cho, Itabashi-ku, Tokyo, Japan.

Miriam Akasbi (M)

Department of Internal Medicine, Hospital Infanta Leonor, Madrid, Spain.

Kyle Thompson (K)

Newcastle NIHR Biomedical Research Centre, The United Kingdom Primary Sjögren's Syndrome Registry, Newcastle upon Tyne, UK.

Antónia Szántó (A)

Division of Clinical Immunology, Faculty of Medicine, University of Debrecen, Hungary.

A Darise Farris (AD)

Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Martina Villa (M)

Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, and Saint Camillus International University of Health Science, UniCamillus, Rome, Italy.

Stefano Bombardieri (S)

Rheumatology Unit, University of Pisa, Italy.

Levent Kilic (L)

Division of Rheumatology, Department of Internal Medicine, Hacettepe University, Faculty of Medicine, Ankara, Turkey.

Abdurrahman Tufan (A)

Department of Internal Medicine, Division of Rheumatology, Gazi University School of Medicine, Ankara, Turkey.

Katja Perdan Pirkmajer (K)

Department of Rheumatology, University Medical Centre, Ljubljana, and Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Slovenia.

Yuhei Fujisawa (Y)

Division of Rheumatology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.

Salvatore de Vita (S)

Division of Rheumatology, Department of Medicine, University of Udine, University Hospital Santa Maria della Misericordia, Udine, Italy.

Nevsun Inanc (N)

Marmara University, School of Medicine, Istanbul, Turkey.

Manuel Ramos-Casals (M)

Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, and Department of Medicine, University of Barcelona, Spain. mramos@clinic.cat.

Classifications MeSH